50
Participants
Start Date
May 31, 2014
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
lanreotide acetate
Somatuline Autogel injection 120mg for first 3 months then 120, 90 or 60 mg administered via the deep subcutaneous route every 28 days
Basingstoke & North Hampshire Hospital, Basingstoke
Queen Elizabeth Hospital, Birmingham
University Hospital Wales, Cardiff
Beatson West of Scotland Cancer Centre, Glasgow
St James's University Hospital, Leeds
University Hospital Aintree, Liverpool
Hammersmith Hospital, London
King's College Hospital, London
Royal Free Hospital, London
Maidstone Hospital, Maidstone
The Christie Hospital, Manchester
Norfolk & Norwich Hospital, Norwich
Royal Hallamshire Hospital, Sheffield
Southampton University Hospital, Southampton
Lead Sponsor
Ipsen
INDUSTRY